Autus Asset Management’s Gilead Sciences GILD Stock Holding History

Autus Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$328K	Hold	3,821	–	–	0.06%	119
2022 Q3	$235K	Hold	3,821	–	–	0.05%	129
2022 Q2	$237K	Sell	3,821 -300	-7%	-$18.6K	0.04%	135
2022 Q1	$245K	Sell	4,121 -450	-10%	-$28.8K	0.04%	137
2021 Q4	$332K	Buy	4,571 +186	+4%	+$12.8K	0.03%	147
2021 Q3	$306K	Hold	4,385	–	–	0.03%	142
2021 Q2	$302K	Sell	4,385 -189	-4%	-$12.6K	0.03%	140
2021 Q1	$295K	Buy	+4,574	New	+$295K	0.03%	140
2020 Q4	–	Sell	-4,589	Closed	-$290K	–	156
2020 Q3	$290K	Sell	4,589 -200	-4%	-$13.9K	0.04%	139
2020 Q2	$368K	Sell	4,789 -46	-1%	-$3.52K	0.05%	121
2020 Q1	$361K	Sell	4,835 -2,142	-31%	-$148K	0.06%	113
2019 Q4	$453K	Buy	+6,977	New	+$454K	0.07%	115

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Autus Asset Management's GILD Position: Q4 2022 in Review

Autus Asset Management held its Gilead Sciences (GILD) position steady in Q4 2022 at 3,821 shares worth $328K. The position accounts for 0.06% of the portfolio, ranked #119.

Autus Asset Management first reported a position in GILD in Q4 2019 and has held it in 12 quarters since. The position peaked at $453K in Q4 2019. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

Autus Asset Management held 3,821 shares of Gilead Sciences worth $328K as of Q4 2022.
Autus Asset Management left its Gilead Sciences share count unchanged in Q4 2022.
Gilead Sciences made up 0.06% of Autus Asset Management's portfolio in Q4 2022, its #119 holding.
Autus Asset Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 12 quarters since.
Autus Asset Management's Gilead Sciences position peaked at $453K in Q4 2019.
1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Autus Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.